Addex Therapeutics (ADXN) Treasury Shares: 2022-2025
Historic Treasury Shares for Addex Therapeutics (ADXN) over the last 3 years, with Jun 2025 value amounting to -$892,014.
- Addex Therapeutics' Treasury Shares rose 7.79% to -$892,014 in Q2 2025 from the same period last year, while for Jun 2025 it was -$892,014, marking a year-over-year increase of 7.79%. This contributed to the annual value of $988,598 for FY2024, which is 2.38% down from last year.
- According to the latest figures from Q2 2025, Addex Therapeutics' Treasury Shares is -$892,014, which was up 7.74% from -$966,882 recorded in Q1 2025.
- Addex Therapeutics' 5-year Treasury Shares high stood at $6.5 million for Q4 2022, and its period low was -$30.0 million during Q1 2022.
- In the last 3 years, Addex Therapeutics' Treasury Shares had a median value of -$223,585 in 2022 and averaged -$17.4 billion.
- In the last 5 years, Addex Therapeutics' Treasury Shares tumbled by 27,178,094.28% in 2023 and then spiked by 100.00% in 2024.
- Over the past 4 years, Addex Therapeutics' Treasury Shares (Quarterly) stood at $6.5 million in 2022, then slumped by 84.27% to $1.0 million in 2023, then declined by 3.18% to $992,791 in 2024, then grew by 7.79% to -$892,014 in 2025.
- Its last three reported values are -$892,014 in Q2 2025, -$966,882 for Q1 2025, and $992,791 during Q4 2024.